61 results about "Skin medications" patented technology

Cosmetic or dermopharmaceutical compositions containing Pseudoalteromonas ferment extract for the treatment and/or care of the skin, scalp and/or nails, preferably to improve the barrier function of the skin, scalp and/or nails, and specifically for the treatment and/or care of those conditions, disorders and/or pathologies of the skin, scalp and/or nails associated with an alteration in the keratinization process.

Topical use of teprenone in a cosmetic or dermopharmaceutical composition as an active preventing and/or limiting the skin cells sénescence and/or protecting the general state of the skin.

Cosmetic or dermopharmaceutical compositions containing, in a dermatologically acceptable carrier, at least one diterpene among: cafestol, kahweol and chemical derivatives are useful for slimming treatments including prevent and/or treat cellulite or orange peel and/or to refine contours of the face, skin firming, to reduce the steatomery of the thighs, to decrease the volume/fatty overload of the spare tire at the hips, to reduce “love handles”, both on men and women.

The invention relates to a novel tyramine derivate and a method for preparing the compound. The invention also relates to a cosmetic or medical skin composition having the compound, as well as the application of the compound in the skin care field, in particular to the application in order to release the over-pigmentation.

Cosmetic or dermopharmaceutical compositions which contain kombucha are disclosed. The present invention further relates to the use of kombucha and cosmetic or dermopharmaceutical compositions containing the same, alone or in combination, for the care of the skin, mucosae and skin appendages, and in particular for preventing the signs of endogenous and/or exogenous ageing.

Personal care products including cosmetics, grooming products and topical pharmaceutical products can be produced including a polypeptide of between 3 and 12 amino acids in length and a ceramide. These formulations are particularly useful in addressing wrinkles in human subjects and in particular facial skin and hands. Certain analogs and derivatives of these polypeptides may be used in these formulations and/or alone. Methods of using these formulations are also disclosed.

The invention relates to a process for the production of granules or powders, suitable as coating agents and binders for oral or dermal pharmaceutical forms, for cosmetics or food supplements, consisting essentially of (a) a copolymer, consisting of free radical-polymerized C1- to C4-esters of acrylic or methacrylic acid and further (meth)acrylate monomers which contain functional tertiary amino groups, (b) 3 to 25% by weight, based on (a), of an emulsifier having an HLB of at least 14, (c) 5 to 50% by weight, based on (a), of a C₁₂- to C₁₈-monocarboxylic acid or of a C₁₂- to C₁₈-hydroxyl compound, where the components (a), (b) and (c) are simultaneously or successively blended or mixed with one another, optionally with addition of a pharmaceutical active compound and/or further customary additives, fused in a heatable mixer, mixed, the melt is cooled and comminuted to give granules or powders.

Short sight, visual fatigue and ischemic ophthalmopathy belong to the cataract diseases of oculopathy and are mostly caused by emotion problems or body fluid loss, blood shortage, weak kidney and liver which lead to the disorder of entrails, no moistening of eyes, blood stasis, etc., thus causing the loss of sight and even other neopathy. The treatment principle is that the traditional Chinese medicine components which can strengthen the liver and the kidney, supplement blood and body fluid, activate blood circulation to dissipate blood stasis, invigorate the spleen, and be beneficial for moistening are selected; the medicinal materials are extracted (63 percent of effective components, 30 percent of film-forming agent and 7 percent of plasticizer) and blended evenly to make the Chinese medicinal plaster with the thickness of 0.08 to 0.12cm and the plaster is then dried at the normal temperature (the temperature is controlled below 40 DEG C), cut and packaged into a finished product. The medicine can be applied to the skin around the eye and be finally acted on the target area in the ocular fundus after being absorbed by capillary vessels of the skin into the blood circulation of the eye.

The invention concerns novel molecules derived from noraporphine, as well as cosmetic and dermopharmaceutical compositions containing one or several of said derivatives, alone or combined with a plant extract, in particular glaucium flavum, and particularly preparations for reducing pigmentation, with anti-ageing effect or for slimming.

A method and formulation for the delivery of an active substance to the skin (epidermis, including the stratum corneum and viable epidermis, and dermis) of a subject. The formulation comprises oil-based or aqueous droplets comprising the active substance within a coating of nanoparticles, particularly silica nanoparticles. The active substance may be suitable for the treatment of a disease or condition which is localised, or at least partially localised, to the skin (eg skin cancer, psoriasis, eczema, infections including bacterial and fungal infections, acne, dermatitis, inflammation, and rheumatoid arthritis).

Extract of a bacterial strain for its use in treatment and/or care of the skin and/or mucous membranes, as well as its cosmetic and/or dermopharmaceutical compositions. In particular, its use for sebum reduction and skin firmness.

The invention discloses an ozagrel ester with the compounds of the ozagrel ester. The ozagrel ester is provided with a chemical structural formula as listed on the right. The compounds of the ozagrel ester comprise an ozagrel ester with the amount of effective treatment and a carrier accepted in medicine. The invention also discloses the preparation methods for the ozagrel ester and the compounds of the ozagrel ester. The ozagrel ester of the invention has good solubility and stability; besides, the compounds of ozagrel ester can be conveniently made into a plurality of liquid, solid, freeze-drying and mucosa or the skin medication agents.

The invention relates to a medicine composition which consists of active components and medicinal auxiliary materials and can directly act on skin. The medicine composition is characterized in that the active components comprise one of glucocorticoids and azulene sulfonate or one of salts of azulene sulfonate.

Ferment extract and exopolysaccharide of a bacterial strain for its use in treatment and/or care of the skin, as well as its cosmetic and/or dermopharmaceutical compositions. In particular, its use for skin aging, skin firmness and hydration.

The invention discloses a drug for treating cervical and lumbar spondylosis. The drug mainly comprises lycopodium clavatum, caulis spatholobi, folium artemisiae argyi, chaenomeles speciosa, radix clematidis, ramulus mori, cortex acanthopanacis, angelica sinensis, notopterygium and phryma leptostachya. The invention further discloses a using method of the drug for treating cervical and lumbar spondylosis. The using method comprises the steps of mixing thedrug with 2-10 kg water and conducting heating so that cervical and lumbar diseased regions can be fumigated through steam. Fumigation is conducted once to twice each day and lasts for 40-50 min each time. By means of the fumigation therapy and the principle that lung governs the skin and hair and opening and closing of sweat pores, through the dispersion of Lung qi, the skin can breathe too, so that gas and medicine exchange is achieved, and medicine directly acts on the skin of the affected part, is absorbed through the skin and then enters the affected part to achieve treatment; meanwhile, the acupoint of the affected part is stimulated, the channel qi of the affected part is stimulated and regulated, the channel of the affected part is unblocked, and then treatment is achieved.

The invention discloses an insulin skin medication paste for diabetes and a preparation method. The insulin skin medication paste is prepared by the following steps: a, dissolving insulin into a triethanolamine-hydrochloric acid buffer liquid, adding a polylactic acid hollow fiber, and carrying out vacuum treatment so as to obtain a polylactic acid fiber with insulin; b, mixing the polylactic acidfiber with sodium salicylate, sitosterol, lecithin, ceramide, ethyecellulose and glycerinum so as to obtain a composite gel ointment; c, under an air isolated condition, coating the surface of a substrate by the composite gel ointment, adhering to a diaphragm, cutting, and packaging, thereby obtaining the insulin skin medication paste. The preparation method has the beneficial effects that the insulin skin medication paste disclosed by the invention has a slow release effect, through micro acupuncturing of the polylactic acid fiber and a skin expansion function of salicylic acid, the skin medication effect of the paste can be effectively improved, and the paste is applicable to an abdomen part, has long-lasting medicinal effects, is very convenient to use and has good application prospects.